SS
Sebastian Schade
Paracelsus Elena Klinik Kassel, Universitätsmedizin Göttingen
Research areas: Medicine · Neurology · Parkinson's Disease Mechanisms and Treatments · Dementia and Cognitive Impairment Research · Gut microbiota and health
0000-0002-6316-6804
Employment
- 2009 - 2022
Education
Education history is unavailable.
Projects & Funding
-
Fellowship of the PPMI Early Stage Investigators Program Michael J. Fox Foundation for Parkinson's Research2022 - 2024
Publications (40)
- Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammation Save
- Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease Save
- Fasting-driven suppression of disease activity in rheumatoid arthritis Save
- Identifying individuals at-risk of developing Parkinson's disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study. Save
- Anosmia and Upper Limb Rigidity—A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α‐Synuclein Seeds Save
- Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory Save
- Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson’s disease Save
- Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Save
- Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based Study. Save
- Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation Save
- Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies Save
- Author Correction: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease Save
- Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset Save
- Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease Save
- Persistent Hyposmia as Surrogate for α-Synuclein-Linked Brain Pathology Save
- Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid spanning from healthy subjects to prodromal and manifest Parkinson’s disease Save
- Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson’s disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome) Save
- Artefactual source of 2-hydroxypyridine Save
- Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals Save
- Proteomics and machine learning identify a distinct biomarker panel to detect prodromal and early Parkinson’s disease Save